Holding(s) in Company

Dechra Pharmaceuticals PLC
13 December 2023
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0009633180

Issuer Name

DECHRA PHARMACEUTICALS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

JPMorgan Chase & Co.

City of registered office (if applicable)

 

Country of registered office (if applicable)

US

4. Details of the shareholder

Name

City of registered office

Country of registered office

J.P. Morgan Securities plc



5. Date on which the threshold was crossed or reached

11-Dec-2023

6. Date on which Issuer notified

13-Dec-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

4.122419

2.869874

6.992293

7963757

Position of previous notification (if applicable)

3.984842

2.620681

6.605523


8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB0009633180


4695161


4.122419

Sub Total 8.A

4695161

4.122419%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 





Sub Total 8.B1




8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Cash-settled Equity Swap

20/02/2024

20/02/2024

Cash

6220

0.005461

Cash-settled Equity Swap

04/03/2024

04/03/2024

Cash

5090

0.004469

Cash-settled Equity Swap

05/06/2024

05/06/2024

Cash

1420344

1.247082

Cash-settled Equity Swap

27/06/2024

27/06/2024

Cash

1682

0.001477

Cash-settled Equity Swap

12/07/2024

12/07/2024

Cash

1390089

1.220518

Cash-settled Equity Swap

31/07/2024

31/07/2024

Cash

39012

0.034253

Cash-settled Equity Swap

17/10/2024

17/10/2024

Cash

74288

0.065226

Cash-settled Equity Swap

04/11/2024

04/11/2024

Cash

17

0.000015

Cash-settled Equity Swap

20/11/2024

20/11/2024

Cash

6340

0.005567

Cash-settled Equity Swap

27/12/2024

27/12/2024

Cash

5890

0.005172

Cash-settled Equity Swap

15/01/2025

15/01/2025

Cash

1531

0.001344

Cash-settled Equity Swap

22/01/2025

22/01/2025

Cash

310663

0.272767

Cash-settled Equity Swap

16/01/2026

16/01/2026

Cash

420

0.000369

Cash-settled Equity Swap

18/06/2027

18/06/2027

Cash

6891

0.006050

Cash-settled Equity Swap

30/05/2028

30/05/2028

Cash

119

0.000104

Sub Total 8.B2


3268596

2.869874%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

JPMorgan Chase & Co.

J.P. Morgan Securities plc

4.106359


6.976233%

JPMorgan Chase & Co.

J.P. Morgan Securities LLC




JPMorgan Chase & Co.

J.P. Morgan SE




10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Chain of controlled undertakings:

JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan Capital Holdings Limited (100%)
J.P. Morgan Securities plc (100%)

JPMorgan Chase & Co.
JPMorgan Chase Holdings LLC (100%)
J.P. Morgan Broker-Dealer Holdings Inc. (100%)
J.P. Morgan Securities LLC (100%)

JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan SE (100%)

12. Date of Completion

13-Dec-2023

13. Place Of Completion

London, United Kingdom

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings